Zimbabwe has declined a major US health deal valued at $367m (272 million pounds) over five years because of the United States' request for confidential information.
The decision became public following a government memo dated December was disclosed, indicating that President Emmerson Mnangagwa deemed the deal was "unbalanced".
An official representative has since explained that the United States was seeking health data for research and profit while was unwilling to share the resulting advantages from future medical innovations.
"We are forced to start the challenging and unfortunate process of ending our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the US had furnished more than $1.9bn in health funding to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has urged more dialogue to secure a agreement agreeable to both sides so the country's critical HIV programme can continue.
Broader Implications
Zimbabwe's decision comes after a comparable situation in neighbouring Kenya, where a high court suspended a similar health funding agreement following legal challenges were raised about the security of Kenyans' medical information.
After resuming office recently, US President Donald Trump has drastically cut overseas assistance and closed the US Agency for International Development (USAID).
The agency had administered assistance for the American government, but Trump stated its expenditure was "inefficient" and his administration was seeking government-to-government deals to boost transparency and accountability.
Based on reports, Sixteen nations in Africa have so far signed these new health pacts, representing more than $18.3bn in new funding.
Details of the Rejected Agreement
The money for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this cooperation could have provided significant benefits for Zimbabwean communities, especially the 1.2 million men, women and children currently on antiretroviral therapy through American-funded programmes," the Ambassador said.
However, official spokesman Nick Mangwana maintained the proposed deal was "unequal".
"The proposal required Zimbabwe to share its biological resources and data over an extended period, without any equivalent promise of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might be developed from that shared data," Mangwana explained.
"In essence, our nation would supply the basic resources for scientific discovery without any assurance that the final treatments would be available to our population should a new pandemic emerge."
Sovereignty and International Frameworks
Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral deals were undermining frameworks previously set up via the global organization.
The spokesperson cited its Pathogen Access and Benefit Sharing system designed to deal with future global health emergencies.
"This framework is intended to guarantee that when a country contributes its information, the resulting advantages – such as medicines and cures – are shared equitably, not monopolised exclusively by those with the capability to develop them."
The government's concerns regarding the US deal "should not be misconstrued as hostility towards the US," he added.
"We encourage ongoing dialogue with our US partners on how future co-operation might be designed in a manner that respects the independence and interests of each country."
Medical Community Reaction
Medical experts stated it acknowledged the government's concerns, but urged that talks need to persist given that much of the country's HIV programmes relied on foreign aid.
"If specific concerns arise, including those involving information security or implementation frameworks, these can frequently be addressed via detailed discussion and mutually agreed protections," the group said.
The situation underscores the complex tensions between accepting crucial international aid and safeguarding local interests in an ever more interconnected world.